InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,529.60
(
0.62%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.68
(
-0.02%
)
Bitcoin
66,274.01
(
2.00%
)

Replies to post #139831 on Biotech Values

Replies to #139831 on Biotech Values

DewDiligence

04/05/12 10:40 AM

#139832 RE: DewDiligence #139831

Zaltrap failed the phase-3 VENICE trial in metastatic CRPC, which tested Taxotere ± Zaltrap in the first-line mCRPC setting. The announcement is in the same PR as the immediately preceding post.

DewDiligence

04/05/12 11:36 AM

#139836 RE: DewDiligence #139831

Correction: The Zaltrap PDUFA date in mCRC is 8/4/12 (not 8/12/12).